Skip to main content
PLOS One logoLink to PLOS One
. 2023 Jun 1;18(6):e0285708. doi: 10.1371/journal.pone.0285708

Optimizing health and nutrition status of migrant construction workers consuming multiple micronutrient fortified rice in Singapore

Femke Hannes 1, Kevin Moon 2,¤, Regina Moench Pfanner 1,*
Editor: James Mockridge3
PMCID: PMC10234550  PMID: 37262034

Abstract

Introduction

A well-nourished workforce is instrumental in eradicating hunger, alleviating poverty, and spurring economic growth. A fifth of the total workforce in high-income countries are migrant workers. Despite the accessibility of nutritious foods in high-income countries, migrant workers often rely on nutrient-poor diets largely consisting of empty calories, which in turn leads to vitamin and mineral deficiency, also called hidden hunger, and resultant productivity loss. Here, we study the magnitude of hidden hunger in male migrant construction workers in Singapore and investigate the impact of consuming fortified rice for 6 consecutive months on the nutrition and health status of these workers.

Methods

140 male migrant workers aged 20–51 years of either Bangladeshi or Indian ethnicity from a single dormitory in Singapore volunteered to participate in the study. In total, 133 blood samples were taken at the start of the study and were used to assess vitamin B12, hemoglobin, ferritin, folate, and zinc levels; a sub-sample underwent for homocysteine testing. Anthropometric measurements and vital signs, such as blood pressure, were recorded before and after the intervention.

Results

The results show that vitamin and mineral deficiency was present, especially folate (59% of workers deficient) and vitamin B12 (7% deficient, 31% marginally deficient). The consumption of fortified rice significantly improved the vitamin, iron and zinc level in the workers and significantly reduced the systolic blood pressure amongst the Bangladeshi migrant workers, specifically.

Conclusion

Our study demonstrates that fortified rice may have a positive impact on male migrant construction worker health and nutrition status at the workplace.

Introduction

Today, one person out of nine in the world goes hungry [1] and the number has been slowly rising since 2014 [2]. Micronutrient malnutrition, also known as hidden hunger, affects more than two billion people globally [3]. Not meeting the required nutrient intakes over a prolonged period leads to serious health consequences. In 2017, a large systematic analysis identified diet as the main risk factor for morbidity and mortality related to non-communicable diseases, overtaking tobacco use. Notably, more deaths were caused by nutrient-poor diets with low intake of foods such as whole grains, fruit, nuts, and seeds than by diets with high intake of trans fats, sugary drinks, and red and processed meats [4].

Affordability and availability of a healthy diversified diet is a major problem around the world, with a substantial part of the population consuming an energy-dense, nutrient-poor diet high in refined carbohydrates and starches and low in animal-source foods including meat, eggs and fish, or fresh vegetables and fruits. In many Asian countries, refined carbohydrates, such as white rice, form 70–80% of daily calories consumed [5]. The State of Food Security and Nutrition in the World 2020 reported that 1.5 billion people could not afford a diet that meets the required levels of essential nutrients [2]. The World Food Programme concurs that economic access is a barrier to providing a nutritious diet, finding a high percentage of households in many low- and middle-income countries unable to achieve the minimum dietary diversity required to meet nutrient needs [6]. For example, in Bangladesh, only 13% of households can afford a diet that meets their nutrient needs, and such a diet now costs twice as much as one that simply meets energy needs [6].

In South Asia in particular, malnutrition is widespread and poses a substantial threat to national economies and public health [79]; iron deficiency alone accounts for a loss of US$5 billion in productivity [10]. Consequently, strategies have been put in place by some governments to provide safety nets such as free meal programs to vulnerable groups. However, migrant workers who leave their country to provide a better livelihood for their family back home often come from less fortunate, food and nutrition insecure households, yet have no access to these subsidies in their adopted country. Surviving on low wages, and housed in dormitory-style accommodation with limited access to cooking facilities and refrigeration, migrant workers often rely on their employer for the provision of food [11]. Consumption of nutrient-dense food, which comes at a significant cost to the worker, may be out of reach, widening the nutrient intake gap even further.

Migrant construction work and other manual labor is integral to the economies of many high- and upper middle-income countries, where migrant workers are predominantly male, make up approximately 5% of the total world population and constitute almost 20% of the national workforce [12]. A well-nourished workforce is instrumental in the eradication of hunger and alleviation of poverty; two key United Nations Sustainable Development Goals [13]. As early as the 1960s, leading health organizations have stressed the importance of workplace nutrition to workers, employers, and governments [1416]. According to the International Labour Office, poor diet at the workplace is costing countries around the world up to 20% in lost productivity [15]. As much as a 30% impairment in physical work capacity and performance is reported in iron-deficient men and women [17].

Investing in human capital through improved nutrition is one way to influence both national economies and public health [13]. Workforce interventions in low- and middle-income countries involving micronutrient fortification of food have effectively addressed micronutrient deficiency in women, children and other vulnerable groups [1824]. However, most of these interventions have been applied to female workers at risk for iron deficiency anemia or other forms of anemia, and have investigated fortification with a single micronutrient, often iron or iodine, but also vitamin A or folic acid [19, 21, 22, 24]. The World Health Organization (WHO) has published a list of micronutrients critical to public health [25]. Besides iron and zinc, vitamin A, B-complex vitamins including folate are of great concern and are well known to have a profound impact on human health and productivity, in particular the relationship of vitamin B interventions and homocysteine levels and blood pressure. Delivering micronutrients via a holistic approach and at scale at the workplace has the potential to reduce micronutrient deficiency, improve mental and physical performance of workers and consequently provides a win-win proposition for the employer, public health, and national economy.

Fortified staple food is a proven and effective way to bridge the nutrient gap at scale and ensures adequate intakes of micronutrients without the need for behavioral change [26, 27]. Rice fortified with vitamins and minerals can serve as a nutritious alternative to the highly polished, nutrient-poor white rice [27]. Since white rice is the leading staple food for Asian migrant construction workers, fortifying white rice offers a cost-effective solution and is easily prepared and implemented at the workplace.

Here, we aim to investigate the magnitude of hidden hunger in male migrant construction workers residing in Singapore and assess the impact of prolonged consumption of multiple-micronutrient-fortified rice on nutrition and health status at the workplace.

Methods

Study site and subjects

The study was conducted between March and September 2018 in a single dormitory in Singapore which housed approximately 180 Indian and Bangladeshi construction workers. The site is licensed in accordance with the Foreign Employee Dormitories Act which governs the working and living conditions of migrant construction workers in Singapore. The workers spend on average 6 days per week from 6 am till 6 pm on the construction site including a 1-hour break for lunch [28]. For most workers, the dormitory/site manager organizes three meals per day, 7 days per week. All meals are prepared by a designated and licensed caterer. Breakfast and lunch are prepared and delivered to the workers in the morning whereas dinner is delivered to the dormitory in the evening. Typically, each lunch and dinner consist of about 500g of cooked white rice with some vegetables and proteins [11]. A rotation of the menus is done every few weeks offering 4 different menus including vegetarian options (see S1 and S2 Tables).

Instead of the planned sample of 180 construction workers for this study, 140 construction workers consented to participate. This reduction is explained by absence of interest, motivation and personal time table conflicts. After a clinical examination and a health interview, 7 workers were excluded from the study due to pre-existing medical conditions (e.g. hepatomegaly, hyperthyroidism, under- or overweight) or chronic disease (e.g. diabetes type 2 or clinical hypertension). In total, 133 construction workers were provided with meals from the same licensed caterer, but with 500 g cooked fortified rice instead of their highly polished white rice for 14 meals per week (lunch and dinner, 7 d per wk) over 26 consecutive weeks (approximately 6 months). All the other food items and quantities on the menu remained the same. The provision of 500 g of cooked rice per meal remained the same throughout the study and is a slight reduction from the initial estimated amount in the study protocol. The workers who participated throughout the whole study received a monthly reduction on their payment to the food caterer, equivalent to approximately 20% of their salary. The workers who did not consent to the study, did not receive the fortified rice and organized their meals by their own choice.

The TREND statement checklist was established to allow transparent reporting of the study (see S1 Checklist).

Study design, sampling and monitoring

The design of the study is a single-center, open label, longitudinal intervention study with a before and after evaluation. The present study was conducted according to the guidelines laid down in the Declaration of Helsinki, and all procedures and amendments thereof involving human subjects were approved by the Parkway Independent Ethics Committee (PIEC/2017/019) and Agri-Food and Veterinary Authority of Singapore. The present trial was registered in the ClinicalTrials.gov Trial Registry as NCT04343508. The trial was registered after subject recruitment began due to a professional oversight; the authors confirm that all ongoing and related trials for this drug/intervention are registered. Informed written consent was obtained after an explanation of the study objectives and procedures in either Tamil or Bengali (see S2 File).

The objectives of this study were 1) to assess the extent of pre-existing nutrient deficiencies and to investigate the effectiveness of a 6-month dietary intervention with fortified rice on hemoglobin (Hb), ferritin, zinc, folate and vitamin B12 levels of migrant construction workers in Singapore and 2) examine the impact of the 6-month dietary intervention on determinants of cardiovascular disease, such as blood pressure, and for a small subset of randomly selected workers, homocysteine concentrations in blood.

At the start of the intervention study, an interview using a general health questionnaire (see health questionnaires S4a in English, S4b in Tamil and S4c in Bengali in S1 File) a clinical examination, and blood pressure and anthropometric measurements of each enrolled study subject were done onsite. We were not able to validate the health questionnaire as the migrant workers were not available due to their working schedule for any additional time except for the health assessment at the start of the intervention. Height and weight were recorded via a column scale with an adjustable measuring rod (BW2150H, Nagata Scale, Tainan City, Taiwan) followed by a Body Mass Index (BMI) calculation in line with the guidelines described by WHO [29]. Blood pressure was obtained under the supervision of a certified nurse using an electronic blood pressure monitor and measured at least three times per subject. A clinical examination and a general health interview were conducted under the supervision of a medical doctor and translator. The health interview collected data on medical history and the use of drugs and dietary supplements. The questionnaire also included questions about habits such as smoking. A blood sample was drawn onsite by a certified phlebotomist. The subject criteria for the collection of blood were defined as: 1) being between 20 and 51 years old, 2) having a BMI between 17.0 to 27.5 kg/m2, 3) understanding and signing informed consent, 4) being free of concomitant medical issues and chronic disease(s), 5) having no prior usage of drugs and/or dietary supplements, and 6) smoking less than 10 cigarettes per day for a prolonged period. In addition, a minimum commitment of 6 consecutive months to the study procedure was required. Note that an amendment had been made to the original study protocol to extend the eligible age for the study from 21–50 y to 20–51 y.

During the intervention, a record was kept by the site manager including the number of pre-packed meals returned to the licensed caterer and days absent due to illness. Compliance monitoring was done at regular intervals by the project manager. A subject was considered fully compliant when having consumed all 14 meals per week offered, moderately compliant when having consumed 8–13 meals per week, or non-compliant when having consumed less than 8 meals per week. Workers who did take their home leave during the intervention would be flagged as moderate or non-compliant depending on the average consumption of meals over the whole intervention.

After 6 consecutive months of follow-up, anthropometric measurements, blood pressure readings and a blood sample were taken from the eligible construction workers.

Safety was assessed and reported according to ICH-GCP guidelines. All Adverse events (AEs) occurring during the study were reported and recorded in a Case Report Form by the study team, whether or not they were considered to be non-serious, serious, or related to the product. Definitions of safety parameters were defined in the study protocol. The AEs were classified by preferred term and body system using MedDRA and tabulated by severity and relationship. Concomitant and pre-study medications were listed by subject ID, summarized by medication class and treatment group, and listed by intervention group.

Fortified rice (interventional product)

The fortified rice kernels produced for this study were generated using hot extrusion technology and are made from white rice flour mixed with premix. The fortified kernels are then blended with polished white rice kernels at a ratio of 1% (1:99) to obtain fortified rice ready for consumption at the required concentrations of micronutrients. Blending was done by a third-party blending company that is licensed under the Singapore laws on food production per good manufacturing practice standards. The fortified rice blend was prepared following an identical cooking method to the unfortified white rice. Each of the pre-packed meals provided to study subjects contained 500g cooked fortified rice.

The micronutrient levels per 100g uncooked fortified rice were: 150 μg vitamin A (vitamin A palmitate), 0.5 mg vitamin B1 (thiamin mononitrate), 7 mg vitamin B3 (niacin amide), 0.6 mg vitamin B6 (pyridoxine hydrochloride), 1 μg vitamin B12 (cyanocobalamin), 130 μg folic acid, 4 mg iron (ferric pyrophosphate), and 6 mg zinc (zinc oxide). Consuming their daily meals, the workers receive the following nutrient support: 500 μg vitamin A; 1.6 mg B1; 23.4 mg B3; 20 mg B6; 3.34 μg B12; 434 μg Folic Acid; 13.36 mg Fe; 20 mg Zn. This is based on 500 g cooked rice (per meal) to be approximately 167 g of uncooked rice (per meal).

Biochemical analysis of blood samples

Eight mL of whole blood were collected from fasting subjects at baseline and after 6 months of intervention by venipuncture into an EDTA-vacutainer and a plain tube without anticoagulants (Becton Dickinson) by a certified phlebotomist. From a randomly selected subset of 53 workers, an extra 5 mL of whole blood were collected in an additional plain tube (Becton Dickinson) for determination of serum homocysteine concentration. These tubes were stored on ice (but not frozen) for a maximum of 8 h prior to arrival in the laboratory. After arrival in the laboratory, whole blood samples underwent a complete blood count and were thereafter immediately centrifuged for 10 minutes at 1000-2000g and the serum or plasma removed and stored at 2 to 8°C until further analysis.

Hemoglobin (Hb) was measured within 24 h of sampling using an automated haematology analyzer (CELL-DYN Ruby System, Abbott Diagnostics, IL, USA) with two independent measuring channels. Serum folate, serum ferritin, vitamin B12 and homocysteine assays were run on the Architect-2000 system (Abbott Diagnostics, IL, USA). Serum zinc was measured using inductively coupled plasma mass spectrometry on the Agilent technologies 7700 series ICP-MS instrument (Agilent Technologies, Inc., CA, USA) and trace element free tubes. Serum zinc was expressed in μg/L.

All laboratory measurements were done according to international standards.

Definition of clinical and biochemical outcomes

Normal reference values in fasting adult males were defined as follows: serum ferritin, ≥15 μg/L [30]; vitamin B12, >220 pmol/L [31]; serum folate, ≥10 nmol/L [32]; hemoglobin (Hb), ≥13 g/dL [17]; serum zinc, ≥11.3 μmol/L [33]; and homocysteine, <15.0 μmol/L [34]. Marginal vitamin B12 level was defined as a concentration of 150–220 pmol/L [31]. Vitamin B12 deficiency was defined as a concentration <150 pmol/L.

BMI was categorized into underweight (BMI<18.5 kg/m2), normal (BMI 18.5–24.9 kg/m2), and overweight (BMI>25.0 kg/m2) according to standard recommendations [29]. The average of all systolic blood pressure measurements taken at a single follow-up visit was used as the mean systolic blood pressure for each study subject. Similarly, the average of all diastolic blood pressure measurements was used as the mean diastolic blood pressure. Hypertension was defined as having a mean systolic blood pressure ≥140 mmHg or a mean diastolic blood pressure ≥ 90 mmHg. “At risk of hypertension” or prehypertension was defined as having a systolic blood pressure of 120–139 mmHg or a diastolic blood pressure of 80–89 mmHg [35]. Normal blood pressure was defined as having a systolic blood pressure <120 mmHg and a diastolic blood pressure of < 80 mmHg.

Statistical analysis

A sample size of 180 participants with a maximum anticipated subject attrition of 22% was estimated based on the following: a paired t-test, a power of 80% to achieve significance on all co-primary endpoints (vitamin B12, hemoglobin, ferritin, folate, and zinc levels) simultaneously (95% power for each primary endpoint individually) and a two-sided alpha of 5% (overall), and an effect size of ≥0.30 for all parameters. The study suffered from high dropout rates; first, with 40 of the original 180 workers who did not report for screening, and second, an additional 40 of the 140 remaining participants who either left the study or declined involvement in the final study visit. The aimed sample size of 140 for an overall power of 80% was not achieved, and therefore, the study might be underpowered to detect significant effects.

For all analyses, statistical significance was defined as a P-value <0.05. SPSS version 26 software (IBM Corp., Released 2019, Armonk, NY, USA) was used for all analyses. Contrary to the study protocol only an Intent-to-treat analysis was considered for the data-analysis. Analysis of outcomes was done with the original continuous measurement values. Paired t-tests were used to compare baseline to post-intervention measurements. A two-sample or independent t-test was used to determine if mean values of subgroups were significantly different. The data have been assessed for normality of the distribution of all the change in indicators; all the indicators were sufficiently close to normally distributed to allow the use of the paired t-test.

In addition, these continuous variables were categorized according to the proportion of workers below or above the consensus cutoffs to define the presence and severity of various health conditions, including hypertension, hyperhomocysteinemia and micronutrient deficiencies. These data were not part of the planned statistical analysis and are descriptively reported in the results. The frequencies of Adverse Events (AEs) are also descriptively reported in the results.

Results

A total of 140 subjects were screened at the start of the study; 133 subjects were enrolled and 7 subjects were excluded for not fulfilling the inclusion criteria (Fig 1). All eligible subjects were male migrants from either Bangladesh or India. About 68% of the workers were between 25–35 y old, 82% had a BMI within normal range (7.5% were underweight and 10.5% were overweight/obese), and 71% had a blood pressure below 140/90 mmHg. Vitamin deficiencies were commonly found; almost 59% of subjects were deficient in folate, and 7% were deficient and 31% marginally deficient in vitamin B12. Hyperhomocysteinemia was detected in 62% of 53 randomly selected workers (Table 1).

Fig 1. Subject flow chart.

Fig 1

Table 1. Overview of the nutrition, blood pressure, and homocysteine status of 133 eligible construction workers.

Total All eligible subjects N = 133
n %
Hypertensive 39 29%
At risk for hypertension 0 0%
Normotensive 94 71%
Anemia (Hb <13 g/dL) 1 1%
Iron deficient (ferritin <15 μg/L) 5 4%
Folate deficient (<10 nmol/L) 78 59%
Vitamin B12 deficient (<150 pmol/L) 9 7%
Vitamin B12 marginal level (150–220 pmol/L) 41 31%
Zinc deficient (<11.3 μmol/L) 7 5%
N = 53*
Homocysteinemia (homocysteine ≥15.0 μmol/L) 33 62%

*A subgroup of 53 construction workers were tested for homocysteine level at baseline which is a slight modification to the original study protocol that estimated to draw blood from 50 construction workers

After 6 months of intervention, an attrition rate of 24.8% was recorded, leaving in total 100 subjects for post-intervention assessment; of these, 64 were of Bangladeshi and 36 were of Indian origin (Fig 1). In total, 14 of the 100 study subjects who had both baseline and endpoint data took home leave during the follow-up period, therefore did not consume the full complement of fortified rice. Five of these study subjects took home leave for more than 6 weeks, four study subjects took 5 to 6 weeks of home leave, and another five study subjects less than 4 weeks (S3A and S3B Tables in S3 Table). A total of 67 subjects experienced adverse events (AEs) during the study of which only 6 were moderate AEs and the remaining were considered mild. None of the AEs led to discontinuations and all AEs were resolved except for one that was ongoing at the time of study closure. AEs were generally flu, headache and similar events that were determined to be mainly unrelated to the administered product. None of the subjects experienced an AE attributed to fortified rice, and none of the subjects had a severe adverse effect (SAE).

When considering the entire sample, the vital signs of the workers did not change significantly from baseline to post-intervention (Table 1). On the other hand, there was increase in hemoglobin, ferritin, zinc, and vitamin B12. Serum folate level did not change significantly (Table 2).

Table 2. Evaluation of the impact of the fortified rice intervention on the vital signs and biochemical nutritional status for all 100 subjects completing the study, and Bangladeshi and Indian subgroups.

All subjects n = 100 Bangladeshi subjects n = 64 Indian subjects n = 36
Mean (SD) Mean change P-value* Mean (SD) Mean change P-value Mean (SD) Mean change P-value
Pulse (beats/min) 70.4 (10.4) -0.27 0.79 71.4 (11.0) -2.01 0.123 68.5 (9.1) 2.84 0.05
Temperature (°C) 36.3 (0.3) 0.04 0.36 36.3 (0.2) -0.07 0.061 36.1 (0.35) 0.22 0.01
Systolic blood pressure (mmHg) 126.6 (13.4) -1.56 0.18 125.6 (12.6) -3.81 0.005 128.5 (14.8) 2.44 0.25
Diastolic blood pressure (mmHg) 82.3 (10.9) 0.45 0.63 80.9 (10.2) -0.66 0.475 84.9 (11.8) 2.44 0.22
Hb (g/dL) 15.5 (1.1) 0.28 <0.001 15.1 (0.9) 0.33 <0.001 15.8 (1.4) 0.19 0.07
Folate (nmol/L) 9.2 (3.9) 0.07 0.79 8.5 (4.2) 0.54 0.11 10.55 (3.1) -0.76 0.07
Ferritin (μg/L) 107.5 (78.1) 10.77 <0.001 122 (79.6) 9.19 0.03 80.1 (68.1) 13.58 0.01
Vitamin B12 (pmol/L) 280.7 (103.5) 20.49 <0.001 307.3 (95.3) 34.02 <0.001 233.6 (101.8) -3.56 0.46
Zinc (μmol/L) 14.3 (1.7) 0.55 0.02 14.4 (1.62) 0.71 0.02 14.0 (1.9) 0.28 0.44
Homocysteine (μmol/L)** 15.1 (3.5) -2.58 <0.001 14.6 (4.1) -3.10 <0.001 16.0 (2.6) -1.77 0.04

* P-values are calculated as one sample t-test, 2-tailed

** Values calculated for only n = 18 subjects with available values; n = 11 Bangladeshi, and n = 7 Indian subjects

Among Bangladeshi subjects, there was a significant drop in systolic blood pressure (Fig 2). In addition, there was a significant increase in the concentrations of hemoglobin, ferritin, zinc, and vitamin B12 (Table 2). Although the folate concentration increased over the course of the study, this change was not statistically significant.

Fig 2. Mean change in blood pressure status after the study intervention.

Fig 2

Among Indian study subjects, only serum ferritin concentration demonstrated a significant increase. The average concentrations of serum ferritin and vitamin B12 at baseline were lower in Indian study subjects than Bangladeshi study subjects (Table 2). In all study subjects combined, homocysteine concentration declined with statistical significance.

The number and proportion of volunteers before and after the intervention with (pre)hypertension, hyperhomocysteinemia, anemia, and deficient for micronutrients (below or above the defined cut-off values) is summarized in Table 3. Overall, the proportion of nutrient-deficient and hypertensive workers post-intervention did not seem different as compared to baseline although this was not statistically tested. The proportion of workers with hyperhomocysteinemia seemed to be lower at post-intervention as compared to baseline but numbers were small.

Table 3. Baseline and post-intervention characteristics of blood pressure, micronutrient deficiencies and hyperhomocysteinemia (number and percentage of participants).

Total All eligible subjects N = 100 Bangladeshi subjects N = 64 Indian subjects N = 36
n % n % n %
Hypertensive Baseline 29 29% 15 23% 14 39%
Endline 23 23% 10 16% 13 36%
At risk for hypertension Baseline 41 41% 28 44% 13 36%
Endline 47 47% 30 47% 17 47%
Normotensive Baseline 30 30% 21 33% 9 25%
Endline 30 30% 24 38% 6 17%
Anemia (Hb <13 g/dL) Baseline 0 0% 0 0% 0 0%
Endline 0 0% 0 0% 0 0%
Iron deficient (ferritin <15 μg/L) Baseline 2 2% 2 3% 0 0%
Endline 1 1% 1 2% 0 0%
Folate deficient (<10 nmol/L) Baseline 64 64% 47 73% 17 47%
Endline 61 61% 43 67% 18 50%
Vitamin B12 deficient (<150 pmol/L) Baseline 7 7% 1 2% 6 17%
Endline 7 7% 1 2% 6 17%
Vitamin B12 marginal level (150–220 pmol/L) Baseline 33 33% 12 19% 21 58%
Endline 31 31% 11 17% 20 56%
Zinc deficient (<11.3 μmol/L) Baseline 4 4% 1 2% 3 8%
Endline 5 5% 2 3% 3 8%
N = 18 N = 11 N = 7
Hyperhomocysteinemia (≥15.0 μmol/L) Baseline 11 61% 6 56% 5 71%
Endline 5 28% 2 18% 3 43%

Discussion

Micronutrient deficiency was diagnosed amongst the male migrant workers at the start of our study. Six months after the consumption of fortified rice, micronutrient levels except folate levels, in all subjects, and homocysteine level in those tested, significantly improved. Systolic blood pressure significantly reduced in the Bangladeshi subjects. To our knowledge, this is the first study involving male migrant construction workers to report on a potential strategy at the workplace to fill the micronutrient gap, and subsequent decline in systolic blood pressure and homocysteine level, which is a risk factor for cardiovascular disease. Our study findings fill an important gap in the literature pertaining to male migrant construction workers health and nutrition status at the workplace.

Tackling the nutrient gap with fortified rice at the workplace

Folate and vitamin B12 deficiencies were commonly diagnosed in the subjects at the start of the study. Moreover, folate deficiency was more prevalent amongst the Bangladeshi workers whereas vitamin B12 deficiency was more often diagnosed amongst the Indian workers. Although their meals typically contained a few tablespoons of stewed or fried vegetables such as lentils, cauliflower, peas, brinjal, potato, bitter gourd or cabbage, some of which are rich sources of folate, prolonged cooking is known to affect folate retention of these foods [36]. Of the Indian workers, 44% consumed a strict vegetarian diet, whereas none of the Bangladeshi workers did. Presumably, their food and nutrition insecure backgrounds, the prolonged and restricted offering of low-quality vegetables or meat and the increased need for B-vitamins and other micronutrients to sustain physically demanding jobs are the root causes for these poor outcomes.

Multi-micronutrient-fortified rice was used to fill the micronutrient gap at the workplace by replacing the nutrient-poor white rice with nutrient-dense fortified rice. Each subject was provided with 2 meals per day containing fortified rice, providing the workers between 1 to 2 times the recommended nutrient intake for all vitamins and minerals included [37].

Despite the increment in daily nutrient consumption, the mean folate and vitamin B12 level remained relatively unchanged in all subjects combined and the Indian subjects, respectively. These findings suggest that 1) poor absorption of vitamin B12 and folate could cause this nutrition deficit to persist in these workers, 2) there might be a need for increased requirements due to a pre-existing nutritional deficit upon arrival at the workplace, 3) there might be a need for increased requirements due to intensity of physical labor or 4) the workers may carry a genetic predisposition for common polymorphisms in gene coding for proteins involved in the one-carbon metabolism. Clinical evidence reports that polymorphisms in methylenetetrahydrofolate reductase and methionine synthase exist in Indians and correlate with decreased serum folate, vitamin B12 and elevated homocysteine level [3842]. Moreover, McNulty and colleagues mention a potential benefit of folate and/or methylenetetrahydrofolate supplementation with riboflavin (a co-factor of the methylenetetrahydrofolate reductase enzyme) in their folate biomarker response which in turn can lower blood pressure, particularly in adults with an impaired one-carbon metabolism [43]. Further studies are required to elucidate the specific benefits of the intervention with methylenetetrahydrofolate instead of—or in combination with—folic acid and including riboflavin in establishing a healthier blood pressure.

The impact of improved workplace nutrition on health

Elevated homocysteine levels have been identified as a relevant biomarker of cardiovascular disease [44]. In our study, the prevalence of hyperhomocysteinemia declined significantly after the consumption of fortified rice. Literature suggests that 5–10% of the general population presents with elevated homocysteine levels in serum [45]. However, in the South Asian population, the prevalence of hyperhomocysteinemia may be as high as 30% to 60% [41, 46]. Studies have shown that when homocysteine levels are elevated by 5 μmol/L, the risk of cerebrovascular disease increases by 59%, and the risk of coronary heart disease increases by 32% [44]. The reduction of homocysteine levels by 3 μmol/L reduces the risk of stroke by 24%, and the risk of ischemic heart disease by 16% [44]. Furthermore, population data and randomized trials have provided strong evidence that an intervention with B-vitamins, such as folic acid alone or in combination with other B-vitamins can significantly reduce stroke risk [47]. In 2017, a Cochrane review reported on an effect favoring interventions with vitamins B6, B12 and folic acid which reduces homocysteine concentration and thus lower the risk of stroke [48]. These findings would suggest that through our intervention with fortified rice containing vitamin B complex, which led to an average 3 μmol/L reduction in homocysteine, a stroke risk reduction of 24% could be predicted.

In addition, a significant reduction in systolic blood pressure was reported amongst the Bangladeshi subjects. Scientific evidence shows a clear benefit of reducing blood pressure on cardiovascular health [49]. Even modest changes such as a 2 mmHg reduction in systolic blood pressure can decrease cardiovascular disease risk by 10% [50]. These findings suggest that the approximately 4 mmHg lowering of the systolic blood pressure observed after the intervention translates to an estimated 15% reduction in cardiovascular disease risk.

The prevalence of hypertension (>140/90 mmHg) amongst the migrant construction workers at start of the study was high at 29% and dropped by 6% after the intervention with fortified rice. This drop was more pronounced in the subgroup of Bangladeshi workers (-7%) compared to the Indian subgroup (-3%). This high prevalence of hypertension has been reported by other studies in young male South Asian migrant workers living abroad [5153].

Further attention is warranted to address the nutrition deficits and health issues of male migrant construction workers in Singapore—increasing awareness amongst employers and the relevant health agencies, providing potential treatment, and working towards the prevention of future deficiencies. These findings showcase that with the introduction of nutrient-dense foods such as fortified rice at the workplace, benefits for both the workers and employers can be achieved.

Strengths and limitations of the study

One limitation of our study is the absence of a control group which means that it was not possible to adjust for existing confounding variables. A decision was made to not include a control group from another dormitory as the variability in conditions due to differing dormitory management and employer standards would have introduced bias into our study, while individual random allocation to control and intervention group was not feasible logistically. All the subjects involved came from the one dormitory whereby subjects were well taken care of, with the same diet and lifestyle and were one coherent group. However, these subjects may not be representative of Singapore’s migrant construction worker population as a whole, limiting our ability to extrapolate findings to the entire population. Another weakness of our study is the inaccurate prediction of iron status, as we did not include measurement of extra markers for inflammation. Therefore, iron deficiency may be underestimated. Another limitation of the study is that the aimed sample size of 140 for an overall power of 80% was not achieved, and therefore, the study might be underpowered to detect significant effects.

Conclusion

This study has shown that hidden hunger is highly prevalent amongst male migrant construction workers in a single dormitory in Singapore. Improving the nutrient density of meals provided to these men at the workplace has been demonstrated to successfully improve their nutritional status and may lower their risk of cardiovascular disease through a reduction in systolic blood pressure and homocysteine level. Furthermore, our findings suggest that thorough health assessments of these workers including micronutrient status should be considered beyond the standard clinical assessments, and that complementary nutrition strategies should be implemented to fill pre-existing nutrient intake gaps. Our study demonstrates that multi-micronutrient-fortified rice may be a suitable vehicle to improve the nutrition status, to bridge these nutrient gaps and systematically eradicate hidden hunger in this population. More research is warranted to further investigate the impact of multi-micronutrient-fortified rice on the health and productivity of male migrant construction workers in Singapore on a larger scale to strengthen the evidence base for potential workplace nutrition programs.

Supporting information

S1 Checklist. TREND statement checklist.

(PDF)

S1 Table. Weekly menu catered to Bangladeshi workers.

(PDF)

S2 Table. Weekly menu catered to Indian workers.

(PDF)

S3 Table

a. Total number of workers on home leave. * subjects do have both baseline and post-intervention. b. Weekly distribution of workers who took home leave. * subjects do have both baseline and post-intervention.

(ZIP)

S1 File

a English version of health questionnaire. b Tamil version of health questionnaire. c Bengali version of health questionnaire.

(ZIP)

S2 File. Study protocol.

(PDF)

Acknowledgments

We thank the migrant construction workers and their supervisors to have participated in this study. We particularly want to thank Yannick Foing and the DSM Nutrition Products (DNP) Singapore team who were instrumental in bringing the different partners together and making this study happen. We also thank the DSM Nutrition Products (DNP) Kaiseraugst team, in particular Maaike Bruins. We are also grateful to the different health staff who were involved in the blood sample collection, laboratory analysis and overall data collection and their respective laboratories and institutions in Singapore. Specific thanks go to SPRIM and OBVIO HEALTH. We are particularly thankful to Bradly A. Woodruff who performed the external statistical analysis and reviewed several versions of the article. We also thank Fabian Rohner for his input to and review of the article.

Data Availability

Data is available from Dryad: https://doi.org/10.5061/dryad.3n5tb2rkx

Funding Statement

Please note that DSM stands for Dutch State Mines. However, DSM never writes out this acronym and is only known under DSM. In the case of our study, it is DNP (DSM Nutrition Products) that funded the study. DSM Nutritional Products (DNP) is a manufacturer and supplier of vitamins. DNP funded the study and had provided scientific inputs to the study design and implementation, but was not involved in data analysis, interpretation and the decision to submit this manuscript. Funding for the development of this manuscript was provided by ibn360 a consultancy agency that helps the public and private sectors to co-create solutions that sustainably improve nutrition; page charges were borne by DSM DNP. The funder provided support in the form of a paid service agreement with ObvioHealth to conduct the clinical trial. RMP works at ibn360 and received financial support by the funder for consultancy. KM was affiliated at 45RICE at the time of the study, a social for-profit business by selling a product or service to the public and acquiring funds through sales. KM has no funding support to disclose. FH was employed by DNP at the time of the study. The specific roles of these authors are articulated in the ‘author contributions’ section.

References

  • 1.2020 Global Nutrition Report—Global Nutrition Report. [cited 18 Nov 2020]. Available: https://globalnutritionreport.org/reports/2020-global-nutrition-report/
  • 2.The state of food security and nutrition in the world 2020. [cited 20 Nov 2020]. Available: https://www.who.int/publications/m/item/state-of-food-security-and-nutrition-in-the-world-2020
  • 3.Hodge J. Hidden hunger: Approaches to tackling micronutrient deficiencies. International Food Policy Research Institute (IFPRI); 2016 [cited 20 Nov 2020]. doi:10.2499/9780896295889_04
  • 4.GBD 2017 Diet Collaborators. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Lond Engl. 2019;393: 1958–1972. doi: 10.1016/S0140-6736(19)30041-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Mohan V, Unnikrishnan R, Shobana S, Malavika M, Anjana RM, Sudha V. Are excess carbohydrates the main link to diabetes & its complications in Asians? Indian J Med Res. 2018;148: 531–538. doi: 10.4103/ijmr.IJMR_1698_18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Fill the Nutrient Gap—Bangladesh Concise Report, December 2019—Bangladesh. In: ReliefWeb [Internet]. [cited 18 Nov 2020]. Available: https://reliefweb.int/report/bangladesh/fill-nutrient-gap-bangladesh-concise-report-december-2019
  • 7.Gamble MV, Ahsan H, Liu X, Factor-Litvak P, Ilievski V, Slavkovich V, et al. Folate and cobalamin deficiencies and hyperhomocysteinemia in Bangladesh. Am J Clin Nutr. 2005;81: 1372–1377. doi: 10.1093/ajcn/81.6.1372 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Obeid OA, Mannan N, Perry G, Iles RA, Boucher BJ. Homocysteine and folate in healthy east London Bangladeshis. Lancet Lond Engl. 1998;352: 1829–1830. doi: 10.1016/s0140-6736(05)79892-5 [DOI] [PubMed] [Google Scholar]
  • 9.Moench-Pfanner R, Kraemer K, Henry J. Time to Recalibrate Nutrition Improvement Strategy? Sight Life. 2018. [Google Scholar]
  • 10.Ross JS, Horton S, Micronutrient Initiative. Economic consequences of iron deficiency. Ottawa: Micronutrient Initiative; 1998. [Google Scholar]
  • 11.Dutta MJ. Food insecurity and health of Bangladeshi workers in Singapore: A culture-centered study. 2015. Available: Available: https://www.healthserve.org.sg/wp-content/uploads/2020/09/FoodInsecurityandHealthofBangladeshiWorkersinSingaporeA.pdf
  • 12.Popova N, Özel MH, International Labour Office, Labour Migration Branch, International Labour Office, Department of Statistics, et al. ILO global estimates on international migrant workers: results and methodology. 2018. [Google Scholar]
  • 13.Drewnowski A. Impact of nutrition interventions and dietary nutrient density on productivity in the workplace. Nutr Rev. 2020;78: 215–224. doi: 10.1093/nutrit/nuz088 [DOI] [PubMed] [Google Scholar]
  • 14.GAIN Convening Paper Series 1—Better nutrition for a healthier workforce. In: Global Alliance for Improved Nutrition (GAIN) [Internet]. [cited 19 Nov 2020]. Available: https://www.gainhealth.org/resources/reports-and-publications/gain-convening-paper-series-1-better-nutrition-healthier
  • 15.Wanjek C. Food at work: workplace solutions for malnutrition, obesity and chronic diseases. Geneva: ILO; 2005. [Google Scholar]
  • 16.Food and Agriculture Organization of the United Nations (FAO). Nutrition and Working Efficiency. Freedom Hunger Campaign. 1966; 57. [Google Scholar]
  • 17.WHO | Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. In: WHO [Internet]. World Health Organization; [cited 19 Nov 2020]. Available: http://www.who.int/vmnis/indicators/haemoglobin/en/
  • 18.Hossain M, Islam Z, Sultana S, Rahman AS, Hotz C, Haque MdA, et al. Effectiveness of workplace nutrition programs on anemia status among female readymade garment workers in Bangladesh: A program evaluation. Nutrients. 2019;11: 1259. doi: 10.3390/nu11061259 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Hotz C, Porcayo M, Onofre G, García-Guerra A, Elliott T, Jankowski S, et al. Efficacy of iron-fortified ultra rice in improving the iron status of women in Mexico. Food Nutr Bull. 2008;29: 140–149. doi: 10.1177/156482650802900208 [DOI] [PubMed] [Google Scholar]
  • 20.Gopaldas T, Gujral S. Empowering a tea-plantation community to improve its micronutrient health. Food Nutr Bull. 2002;23: 143–152. doi: 10.1177/156482650202300203 [DOI] [PubMed] [Google Scholar]
  • 21.Li R, Chen X, Yan H, Deurenberg P, Garby L, Hautvast JG. Functional consequences of iron supplementation in iron-deficient female cotton mill workers in Beijing, China. Am J Clin Nutr. 1994;59: 908–913. doi: 10.1093/ajcn/59.4.908 [DOI] [PubMed] [Google Scholar]
  • 22.Blakstad MM, Nevins JEH, Venkatramanan S, Przybyszewski EM, Haas JD. Physical activity and work productivity in response to iron and iodine double-fortified salt trial in Indian tea estate workers. FASEB J. 2016;30: 150.5–150.5. doi: 10.1096/fasebj.30.1_supplement.150.5 [DOI] [Google Scholar]
  • 23.Sridevi D, Radhaisri S. Impact of micronutrient fortified food supplement on nutritional profile among ginning women workers. 2013. doi: 10.7897/2277-4343.04414 [DOI] [Google Scholar]
  • 24.Wenger MJ, Murray-Kolb LE, Nevins JE, Venkatramanan S, Reinhart GA, Wesley A, et al. Consumption of a double-fortified salt affects perceptual, attentional, and mnemonic functioning in women in a randomized controlled trial in India. J Nutr. 2017;147: 2297–2308. doi: 10.3945/jn.117.251587 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.WHO | The world health report 2000—Health systems: improving performance. In: WHO [Internet]. World Health Organization; [cited 19 Nov 2020]. Available: https://www.who.int/whr/2000/en/
  • 26.Sight and Life Supplement: Scaling Up Rice Fortification—ENGLISH. In: Issuu [Internet]. [cited 19 Nov 2020]. Available: https://issuu.com/sight_and_life/docs/scaling-up-rice-fortification-wfp-r_cf69719a60c15a
  • 27.Geneva: World Health Organizaton (WHO). Guideline: fortification of rice with vitamins and minerals as a public health strategy. 2018 [cited 19 Nov 2020]. Available: https://www.who.int/publications-detail-redirect/9789241550291 [PubMed]
  • 28.Harrigan N, Koh CY. Vital yet vulnerable: Mental and emotional health of South Asian migrant workers in Singapore. 2015; 53. [Google Scholar]
  • 29.WHO | Physical status: the use and interpretation of anthropometry. In: WHO [Internet]. World Health Organization; [cited 19 Nov 2020]. Available: https://www.who.int/childgrowth/publications/physical_status/en/
  • 30.WHO | Serum ferritin concentrations for the assessment of iron status and iron deficiency in populations. In: WHO [Internet]. World Health Organization; [cited 19 Nov 2020]. Available: http://www.who.int/vmnis/indicators/ferritin/en/
  • 31.Allen LH. Vitamin B-12. Adv Nutr. 2012;3: 54–55. doi: 10.3945/an.111.001370 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.WHO | Serum and red blood cell folate concentrations for assessing folate status in populations. In: WHO [Internet]. World Health Organization; [cited 19 Nov 2020]. Available: http://www.who.int/vmnis/indicators/serum_RBC_folate_update2015/en/
  • 33.Hess SY, Peerson JM, King JC, Brown KH. Use of serum zinc concentration as an indicator of population zinc status. Food Nutr Bull. 2007;28: S403–S429. doi: 10.1177/15648265070283S303 [DOI] [PubMed] [Google Scholar]
  • 34.Malinow MR, Bostom AG, Krauss RM. Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation. 1999;99: 178–182. doi: 10.1161/01.cir.99.1.178 [DOI] [PubMed] [Google Scholar]
  • 35.The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) | NHLBI, NIH. [cited 23 Feb 2021]. Available: https://www.nhlbi.nih.gov/health-topics/seventh-report-of-joint-national-committee-on-prevention-detection-evaluation-and-treatment-high-blood-pressure
  • 36.McKillop DJ, Pentieva K, Daly D, McPartlin JM, Hughes J, Strain JJ, et al. The effect of different cooking methods on folate retention in various foods that are amongst the major contributors to folate intake in the UK diet. Br J Nutr. 2002;88: 681–688. doi: 10.1079/BJN2002733 [DOI] [PubMed] [Google Scholar]
  • 37.Allen LH, Carriquiry AL, Murphy SP. Perspective: Proposed Harmonized Nutrient Reference Values for Populations. Adv Nutr Bethesda Md. 2020;11: 469–483. doi: 10.1093/advances/nmz096 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10: 111–113. doi: 10.1038/ng0595-111 [DOI] [PubMed] [Google Scholar]
  • 39.Paradkar MU, Padate B, Shah SAV, Vora H, Ashavaid TF. Association of genetic variants with hyperhomocysteinemia in Indian patients with thrombosis. Indian J Clin Biochem IJCB. 2020;35: 465–473. doi: 10.1007/s12291-019-00846-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Hughes K, Ong CN. Homocysteine, folate, vitamin B12, and cardiovascular risk in Indians, Malays, and Chinese in Singapore. J Epidemiol Community Health. 2000;54: 31–34. doi: 10.1136/jech.54.1.31 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Refsum H, Yajnik CS, Gadkari M, Schneede J, Vollset SE, Orning L, et al. Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians. Am J Clin Nutr. 2001;74: 233–241. doi: 10.1093/ajcn/74.2.233 [DOI] [PubMed] [Google Scholar]
  • 42.Chambers JC, Ireland H, Thompson E, Reilly P, Obeid OA, Refsum H, et al. Methylenetetrahydrofolate reductase 677 C—>T mutation and coronary heart disease risk in UK Indian Asians. Arterioscler Thromb Vasc Biol. 2000;20: 2448–2452. doi: 10.1161/01.atv.20.11.2448 [DOI] [PubMed] [Google Scholar]
  • 43.McNulty H, Strain JJ, Hughes CF, Pentieva K, Ward M. Evidence of a role for O\one-carbon metabolism in blood pressure: can B vitamin intervention address the genetic risk of hypertension owing to a common folate polymorphism? Curr Dev Nutr. 2020;4: nzz102. doi: 10.1093/cdn/nzz102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ. 2002;325: 1202. doi: 10.1136/bmj.325.7374.1202 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Refsum H, Ueland PM, Nygård O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med. 1998;49: 31–62. doi: 10.1146/annurev.med.49.1.31 [DOI] [PubMed] [Google Scholar]
  • 46.Carmel R, Mallidi PV, Vinarskiy S, Brar S, Frouhar Z. Hyperhomocysteinemia and cobalamin deficiency in young Asian Indians in the United States. Am J Hematol. 2002;70: 107–114. doi: 10.1002/ajh.10093 [DOI] [PubMed] [Google Scholar]
  • 47.Wang X, Qin X, Demirtas H, Li J, Mao G, Huo Y, et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet Lond Engl. 2007;369: 1876–1882. doi: 10.1016/S0140-6736(07)60854-X [DOI] [PubMed] [Google Scholar]
  • 48.Martí-Carvajal AJ, Solà I, Lathyris D, Dayer M. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev. 2017;8: CD006612. doi: 10.1002/14651858.CD006612.pub5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. The Lancet. 2016;387: 957–967. doi: 10.1016/S0140-6736(15)01225-8 [DOI] [PubMed] [Google Scholar]
  • 50.Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet Lond Engl. 2002;360: 1903–1913. doi: 10.1016/s0140-6736(02)11911-8 [DOI] [PubMed] [Google Scholar]
  • 51.Reddy KS. Cardiovascular disease in non-Western countries. N Engl J Med. 2004;350: 2438–2440. doi: 10.1056/NEJMp048024 [DOI] [PubMed] [Google Scholar]
  • 52.Shah SM, Loney T, Dhaheri SA, Vatanparast H, Elbarazi I, Agarwal M, et al. Association between acculturation, obesity and cardiovascular risk factors among male South Asian migrants in the United Arab Emirates—a cross-sectional study. BMC Public Health. 2015;15: 204. doi: 10.1186/s12889-015-1568-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Agyemang C, Bhopal RS. Is the blood pressure of South Asian adults in the UK higher or lower than that in European white adults? A review of cross-sectional data. J Hum Hypertens. 2002;16: 739–751. doi: 10.1038/sj.jhh.1001488 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Jamie Royle

18 Feb 2022

PONE-D-21-12903Optimizing health and nutrition status of migrant construction workers consuming multiple micronutrient fortified rice in SingaporePLOS ONE

Dear Dr. Moench Pfanner,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The manuscript has been evaluated by two reviewers, and their comments are available below.

The reviewers have raised a number of major concerns. They request copyediting to ensure the language and text of the study is more readable and easy to follow. The reviewers also note concerns about the statistical analyses presented, and they request more appropriate tests to be used and a re-analyses of the data to be completed.

Could you please carefully revise the manuscript to address all comments raised?

Please submit your revised manuscript by Apr 03 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Jamie Royle

Associate Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for submitting your clinical trial to PLOS ONE and for providing the name of the registry and the registration number. The information in the registry entry suggests that your trial was registered after patient recruitment began. PLOS ONE strongly encourages authors to register all trials before recruiting the first participant in a study.

As per the journal’s editorial policy, please include in the Methods section of your paper:

a) your reasons for your delay in registering this study (after enrolment of participants started);

b) confirmation that all related trials are registered by stating: “The authors confirm that all ongoing and related trials for this drug/intervention are registered".

3. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. If the original language is written in non-Latin characters, for example Amharic, Chinese, or Korean, please use a file format that ensures these characters are visible.

4. Please state whether you validated the questionnaire prior to testing on study participants. Please provide details regarding the validation group within the methods section.

5. Please expand the acronym “DSM” (as indicated in your financial disclosure) so that it states the name of your funders in full.

This information should be included in your cover letter; we will change the online submission form on your behalf.

6. Thank you for stating the following in the Competing Interests section: "The authors have declared that no competing interests exists for this publication. However, two authors have been supported financially in the beginning of the study by either being an employee of DSM (FH) or an independent consulting firm (RMP) to give input to the study design. At the time of the study implementation one author (KM) was working for 45RICE, a social enterprise dedicated to improving lives through nutrition. DSM’s financial support had no influence on the statistical analysis which was conducted independently and on writing of the article. The authors alone are responsible for the views expressed in this publication."

We note that one or more of the authors have an affiliation to the commercial funders of this research study: Ibn360 and 45RICE

a. Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form.

Please also include the following statement within your amended Funding Statement. 

“The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.”

If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement. 

b. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc.  

Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests). If this adherence statement is not accurate and  there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf.

7. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. 

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: No

Reviewer #2: No

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: A clinical trial was conducted which aimed to study the impact of consuming fortified rice for six months on nutrient levels and vital health status of migrant workers in Singapore. A high percentage of migrant workers exhibited folate and vitamin B12 deficiencies. Consuming fortified rice increased vitamin, iron, and zinc levels. In the subset of Bangladeshi migrant workers, a reduction in systolic blood pressure was observed from pre to post-intervention.

Major revisions:

1- Thoroughly proofread the manuscript. In many instances, phraseology is non-standard.

2- An underlying assumption of the chi-square test is independent samples. Thus, it is inappropriate to compare baseline and post-intervention proportions (percentages) using the chi-square test.

3- Include p-values in the text to support claims of statistical significance.

Minor revisions:

1- Abstract: The term “constitute” in the second sentence is used inappropriately.

2- Clarify the use of the terms “status” and “concentrations” in the abstract. Perhaps “levels” is a more precise term.

3- Abstract: Provide percentages of those with nutrient deficiencies.

4- Line 221: Replace the following two sentences with the suggestion below. “To minimize the inter-individual component covariance, the difference between baseline and endline measurements for each individual survey subject was calculated. P values were calculated using a one-sample t-test comparing the average difference to zero.” Suggested replacement: “Paired t-tests were used to compare baseline to post-intervention measurements.” Revise line 260 accordingly.

5- Normal distribution of data is an underlying assumption of the paired or independent t-test. Indicate if the data was checked for normality prior to applying these tests.

5- The term “endpoint” is unclear. Perhaps "post-intervention" is better.

6- Line 253: Revise: When considering the entire sample, the vital signs of the workers did not change significantly from baseline to post-intervention.

7- Line 255: Revise to: increase in the hemoglobin, ferrin, zinc, and vitamin B12 levels.

8- P-values never equal zero. Express small p-values as p < 0.001.

9- Lines 263, 266, 269, 270, 271: Within the text, provide the p-values to support the claims.

10- Throughout the manuscript, provide the frequencies that correspond to the percentages.

11- State and justify the study’s target sample size with a pre-study statistical power calculation.

The power calculation should include: (1) the estimated outcomes in each group; (2) the α (type I) error level; (3) the statistical power (or the β (type II) error level); (4) the target sample size and (5) for continuous outcomes, the standard deviation of the measurements.

Reviewer #2: Abstract - Need data to be showed to indicate the improvement of nutrtional status (as mentioned)

Introduction - 1.Explain the relationship between nutrient deficiencies in relation to homocystein and blood pressure.

2. Are there the previous studies / data of nutritional status of male worker in Singapore ? why is important compare to other group of population?

Method 1. Expain about how to select the study site ? and sample size calculation ?

2. Participant was given 500 g cooked rice per day or per meal (line no .119,126)

3. Line 181-184 ...100 g uncooked rice equal to how much for cooked rice?

4. Explain about the nutrients level which participant was recieved form fortified rice / day

5. Blood collection for serum Zn need to be collected, prepared with special condition to prevent contatimination e.g. all supplied used for blood collection need to be the trace element free apparatus (https://www.izincg.org/new-blog-1/2021/1/10/comparison-of-laboratory-instrument-types-for-analysis-of-plasma-or-serum-zinc-concentration) ... For my opinion, results of serum Zn may not be reliable.

6. How to control confounding factors e.g. life stye, diet, genetic

7. What 's the QC procedure / or data of refference materials for the biochemical data.

8. Why the author used independent t-test ? (since participants are the same group)

Results

1. Data need to be revised if statistical analysis would change

2. Restults of serum Zn should be removed since they not reliable

3. I would suggest that the data should be presented for both pre - and post-in the same table / figure

and the text need to be changed accordingly

4. The text need to be re-write to be more clearly and logically manner (make it mor easy to understand)

Discussion and conclusion

1. Line 287. What's the indicator which show " micronutrient deficiency was commonly reported amongst the male migrant worker" line 374 "This study has shown that hidden hunger is highly prevalent" in this study

2. Any other underlining cause or confounding factor contributed in the results e.g. life stye, diet, genetic

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 1

George Vousden

18 Jul 2022

PONE-D-21-12903R1Optimizing health and nutrition status of migrant construction workers consuming multiple micronutrient fortified rice in SingaporePLOS ONE

Dear Dr. Moench Pfanner,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The concerns noted by the reviewers have been addressed. However, during my own review of the manuscript I noted some potential ethical concerns that should be addressed before the manuscript is published: Your clinical trial was conducted in a dormitory. Your manuscript indicates that 140 of the ~180 members of the dormitory consented to participate in the study. Please update your manuscript to indicate what food individuals who did not consent to take part received. Did they also receive the fortified rice? If individuals that did not consent to take part were given the fortified rice, despite not consenting to take part in the study, please discuss how the associated ethical concerns with this were mitigated.

Please submit your revised manuscript by Aug 29 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

George Vousden

Deputy Editor in Chief

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 2

Callam Davidson

28 Sep 2022

PONE-D-21-12903R2Optimizing health and nutrition status of migrant construction workers consuming multiple micronutrient fortified rice in SingaporePLOS ONE

Dear Dr. Moench Pfanner,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please see below for additional comments from the editor that require a response.

Please submit your revised manuscript by Nov 12 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Callam Davidson

Editorial Office

PLOS ONE

Additional Editor Comments:

The following content currently found in your Financial Disclosure should be relocated to your Competing Interests: ‘RMP works at ibn360 and received financial support by the funder for consultancy. KM was affiliated at 45RICE at the time of the study, a social for-profit business by selling a product or service to the public and acquiring funds through sales. FH was employed by DNP at the time of the study.’

Please confirm whether the informed consent was written or verbal, and include this information in your Methods.

Line 77: Please update ‘1960’s’ to ‘1960s’.

Line 121: Please update ‘andS2’ to ‘and S2’.

Your TREND checklist is missing details of how sample size was calculated, however this information is contained within the manuscript (at lines 238-245). Please update your checklist to reflect this.

Please also cite your TREND checklist in the Methods.

Your protocol mentions adverse event monitoring, but this is not reported in the manuscript – please update your manuscript and TREND checklist to include this information.

There is a discrepancy between the protocol and clinical trail registry information at https://clinicaltrials.gov/ct2/show/NCT04343508. Your primary and secondary endpoints do not match. Please explain this discrepancy and ensure the correct information is reported in the manuscript. Primary and secondary outcomes ought to be clearly demarcated in the Abstract, Methods, and the Results.

Line 204: Please state the number of randomly selected workers from whom additional blood was planned for collection (I believe this information is located at line 270).

Line 245: The underpowered nature of the study needs to be stated as a limitation in your Discussion.

Line 248: Please include the rationale for this deviation from the protocol.

Line 298: Please updated to ‘statistically significant’.

Line 305: Please justify the decision not to perform statistical analysis. I do not feel that the data presented in Table 3 necessarily support the statements on lines 304-307.

Table 3: Please consider including gridlines to make this table easier to read.

Line 320: Please avoid overstating conclusions based on the findings presented – please temper the statement ‘an effective strategy’ by adding ‘potentially’, or similar.

Line 411: In a similar vein, please temper or remove the statement ‘multi-micronutrient-fortified rice may be the ideal vehicle to optimize the health status’, as the findings from this study cannot support this claim.

Line 426: From the information presented, it appears BAW may qualify for authorship based on ICMJE criteria. Please review https://journals.plos.org/plosone/s/authorship and determine whether BAW ought to be included as an author.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 3

Richard Ali

16 Jan 2023

PONE-D-21-12903R3Optimizing health and nutrition status of migrant construction workers consuming multiple micronutrient fortified rice in Singapore​PLOS ONE

Dear Dr. Moench Pfanner,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Thank you very much for your continued work on revising the submitted manuscript. The manuscript has been evaluated by a reviewer and they have provided minor comments which may be seen below. 

Could you please revise the manuscript to carefully address the concerns raised?

Please submit your revised manuscript by Feb 27 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Richard Ali

Associate Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

********** 

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

********** 

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

********** 

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

********** 

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

********** 

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Minor Revisions:

1- Tables 1 and 3: Remove the equals sign in the table header "n=".

2- Line 304 contains a grammatical error; the verb is missing. "and none of the subjects a severe adverse effect (SAE)."

3- Line 437: Replace "pick up" with "detect".

Note that line numbers refer to those in the track changes version of the manuscript.

********** 

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 4

James Mockridge

2 May 2023

Optimizing health and nutrition status of migrant construction workers consuming multiple micronutrient fortified rice in Singapore

PONE-D-21-12903R4

Dear Dr. Moench Pfanner,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

James Mockridge

Staff Editor

PLOS ONE

Additional Editor Comments (optional):

Abstract, line 36: in view of a comment in a previous decision regarding overstating conclusions, please ensure that this is also attended to in the Abstract. Please change to: Our study demonstrates that fortified rice may have a positive impact on male migrant...."

Please make this change before supplying the final files for your manuscript. 

Acceptance letter

James Mockridge

22 May 2023

PONE-D-21-12903R4

Optimizing health and nutrition status of migrant construction workers consuming multiple micronutrient fortified rice in Singapore

Dear Dr. Moench Pfanner:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr James Mockridge

Staff Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. TREND statement checklist.

    (PDF)

    S1 Table. Weekly menu catered to Bangladeshi workers.

    (PDF)

    S2 Table. Weekly menu catered to Indian workers.

    (PDF)

    S3 Table

    a. Total number of workers on home leave. * subjects do have both baseline and post-intervention. b. Weekly distribution of workers who took home leave. * subjects do have both baseline and post-intervention.

    (ZIP)

    S1 File

    a English version of health questionnaire. b Tamil version of health questionnaire. c Bengali version of health questionnaire.

    (ZIP)

    S2 File. Study protocol.

    (PDF)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Attachment

    Submitted filename: Response to Reviewers July 30.docx

    Attachment

    Submitted filename: Response to Reviewer Letter 31 October 2022.docx

    Attachment

    Submitted filename: ResponseToReviewers18Jan.docx

    Data Availability Statement

    Data is available from Dryad: https://doi.org/10.5061/dryad.3n5tb2rkx


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES